AI in Drug Discovery: Worldwide Market Forecasts & Opportunity Assessment (2019-2024)

12/12/2019 10:15:49 AM

(MENAFN- PR Newswire) DUBLIN, Dec. 12, 2019 /PRNewswire/ -- The "Artificial Intelligence (AI) in Drug Discovery Market by Component (Software, Service), Technology (ML, DL), Application (Neurodegenerative Diseases, Immuno-Oncology, CVD), End User (Pharmaceutical & Biotechnology, CRO), Region - Global forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

The global AI in the drug discovery market is projected to reach USD 1,434 million by 2024 from USD 259 million in 2019, at a CAGR of 40.8% during the forecast period.

Growing number of cross-industry collaborations and partnerships and the need to control drug discovery & development costs and reduce the overall time taken in this process are the key factors driving the AI in the drug discovery market.

Growth in this market is mainly driven by growing number of cross-industry collaborations and partnerships, the need to control drug discovery & development costs and reduce the overall time taken in this process, the rising adoption of cloud-based applications & services, and the impending patent expiry of blockbuster drugs. On the other hand, a lack of data sets in the field of drug discovery and the inadequate availability of skilled labor are some of the factors challenging the growth of the market. The immuno-oncology segment accounted for the largest share in 2019. Based on application, the artificial intelligence in the drug discovery market is segmented into neurodegenerative diseases, immuno-oncology, cardiovascular disease, metabolic diseases, and other applications. The immuno-oncology segment accounted for the largest share of 44.6% of the AI in the drug discovery market in 2018, owing to the increasing demand for effective cancer drugs.

Neurodegenerative diseases form the fastest-growing application segment, with a CAGR of 42.9% during the forecast period. The ability of AI to discover drugs for complex diseases and the emphasis of market players on providing AI-based platforms for neurological diseases are responsible for the fast growth of this application segment. The Research centers and academic & government institutes segment to register the highest growth rate in the forecast period. Based on end-user, the AI in the drug discovery market is segmented into pharmaceutical & biotechnology companies, contract research organizations, and research centers and academic, & government institutes.

In 2018, the pharmaceutical & biotechnology companies segment accounted for the largest share in the AI in the drug discovery market. AI and machine learning to allow pharmaceutical companies to operate more efficiently and substantially improve success rates at the early stages of drug development. This is one of the major factors driving the growth of this market.

Research centers and academic & government institutes are expected to show the highest growth of 43.6%.during the forecast period. The growth of the CROs segment is tied to that of pharmaceutical & biotechnology companies, as the rise in research and production activity will ensure sustained demand for contract services. North America to be the largest and the fastest-growing regional market. North America, which comprises the US, Canada, and Mexico, forms the largest market for AI in drug discovery. These countries have been early adopters of AI technology in drug discovery and development. In the North American market, the US is a significant contributor. Also, prominent AI technology providers, such as IBM, Google, Microsoft, NVIDIA, and Intel, are headquartered in the US; their strong presence is a key contributor to market growth.

Other drivers include the well-established pharmaceutical industry, high focus on R & D & substantial investment, and the presence of globally leading pharmaceutical companies. These are some of the major factors responsible for the large share and high growth rate of this market.

Key Topics Covered

1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 4.1 Market Overview4.2 Market, By Offering (2019-2024)4.3 Market for Machine Learning, By Type & Region (2018)4.4 Market: Geographic Growth Opportunities 5 Market Overview 5.1 Introduction5.2 Market Dynamics5.2.1 Market Drivers5.2.1.1 Growing Number of Cross-Industry Collaborations and Partnerships5.2.1.2 Need to Control Drug Discovery & Development Costs and Reduce Time5.2.1.3 Patent Expiry5.2.2 Market Opportunities5.2.2.1 Growing Biotechnology Industry5.2.2.2 Emerging Markets5.2.3 Market Challenges5.2.3.1 Limited Availability of Data Sets 6 Market, By Offering 6.1 Introduction6.2 Software6.2.1 Benefits Offered By Software in Drug Discovery & Strong Demand Among End Users are Driving Market Growth6.3 Services6.3.1 Services Segment to Witness the Highest Growth During the Forecast Period 7 Market, By Technology 7.1 Introduction7.2 Machine Learning7.2.1 Increasing Adoption of Ml By Research Centers & Pharmaceutical Companies to Support the Growth of This Segment7.2.2 Deep Learning7.2.3 Supervised Learning7.2.4 Reinforcement Learning7.2.5 Unsupervised Learning7.2.6 Other Machine Learning Technologies7.3 Other Technologies 8 Market, By Application 8.1 Introduction8.2 Immuno-Oncology8.2.1 High Prevalence of Cancer and Shortage in the Supply of Cancer Drugs are the Key Factors Driving Market Growth8.3 Neurodegenerative Diseases8.3.1 AI is Being Used to Resolve Existing Challenges in Neurological Disease Drug Development8.4 Cardiovascular Disease8.4.1 Rising Demand for Cvd Drugs is Driving Market Growth8.5 Metabolic Diseases8.5.1 Role of AI in Uncovering Small-Molecule Therapies is Driving Its Adoption in This Segment8.6 Other Applications 9 Market, By End-user 9.1 Introduction9.2 Pharmaceutical & Biotechnology Companies9.2.1 Rising Demand for Solutions to Cut Time and Costs of Drug Development have Drawn End-User Attention to AI9.3 Contract Research Organizations9.3.1 Growing Trend of Outsourcing Provides Significant Opportunities for Cros9.4 Research Centers and Academic & Government Institutes9.4.1 This Segment is Expected to Grow at the Highest CAGR During the Forecast Period 10 Market, By Region 10.1 Introduction10.2 North America10.2.1 US10.2.1.1 Strong Economy and Trend of Early Adoption of Technologies are Driving Market Growth in the US10.2.2 Canada10.2.2.1 Growing Research on AI Technologies and Emergence of New Ai-Based Start-UPS Will Support the Market in Canada10.2.3 Mexico10.2.3.1 Government Initiatives Will Support Market Growth in Mexico10.3 Europe10.3.1 UK10.3.1.1 The UK Holds the Largest Share of the European Market10.3.2 Germany10.3.2.1 Government Support and Favorable Training Programs are Major Market Drivers in Germany10.3.3 France10.3.3.1 Strong Government Support and Favorable Strategies & Initiatives Form Key Drivers of the Market in France10.3.4 Rest of Europe10.4 Asia Pacific10.4.1 Japan10.4.1.1 Japan Dominates the APAC Market for AI in Drug Discovery10.4.2 China10.4.2.1 Growing Cmos Market and Cross-Industry Collaborations are Factors Responsible for the Growth of the Market in China10.4.3 India10.4.3.1 Steady Adoption of AI Technologies Will Drive Market Growth in India10.4.4 Rest of Asia Pacific10.5 Rest of the World 11 Competitive Landscape 11.1 Overview11.2 Market Share Analysis11.3 Competitive Leadership Mapping11.3.1 Visionary Leaders11.3.2 Dynamic Differentiators11.3.3 Innovators11.3.4 Emerging Companies11.4 Competitive Situation and Trends11.4.1 Product Launches and Enhancements11.4.2 Expansions11.4.3 Acquisitions11.4.4 Other Strategies 12 Company Profiles 12.1 Microsoft Corporation12.2 NVIDIA Corporation12.3 IBM Corporation12.4 Google (A Subsidiary of Alphabet Inc.)12.5 Atomwise, Inc.12.6 Deep Genomics12.7 Cloud Pharmaceuticals, Inc.12.8 Insilico Medicine12.9 Benevolentai12.10 Exscientia12.11 Cyclica12.12 Bioage12.13 Numerate12.14 Numedii, Inc.12.15 Envisagenics12.16 Twoxar, Incorporated12.17 Owkin, Inc.12.18 Xtalpi, Inc.12.19 Verge Genomics12.20 Berg LLC

For more information about this report visit https://www.researchandmarkets.com/r/w8k91v

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets